Early animal and laboratory studies have explored its potential role in tissue repair and inflammation, but its cardiovascular effects and risks in humans remain unknown
1514781 Chiba A, Kusunoki S, Shimizu T, et al
Severe or blood glucose confirmed symptomatic hypoglycemia (glucose of 56 mg/dL or less) occurred in 6.5% and 10.4% of patients when semaglutide 0.5 mg and 1 mg, respectively, when coadministered with a sulfonylurea
BPC-157 Dosage Protocol by Use Case As someone whos been using and recommending BPC-157 for decades, here is the practical framework I share in Living A Fully Optimized Life and the rest of my books and courses: Acute Injuries (Muscle Tears, Tendon Damage, Ligament Strains) 250500 mcg subcutaneously, twice daily (once in the morning and once in the evening) Dosing near the site of injury may provide additional local benefit, though the compound distributes systemically regardless of injection location
Signaling Pathways Most Frequently Cited Across the peer-reviewed BPC-157 literature, two signaling axes are referenced most often: 4a
#Ophthalmology #Ophthotwitter #Scicomm To view or add a comment, sign in Milestone Update Three years ago, we backed this innovative neurovascular technology through a dedicated SPV
